You are viewing: US Biosensors Market analysis
Part of: Biosensors Market (Global)

The US Biosensors Market was valued at $4386.4 Million in 2025 and projected to reach to $7237.9 Million by 2030, representing a compound annual growth rate of 10.5%. The US biosensors market is positioned for sustained growth through 2030, supported by increasing healthcare expenditure, aging population demographics, and technological breakthroughs in wearable and implantable biosensor devices.

US Biosensors Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Biosensors Market Trends and Insights

  • This expansion reflects the US's leadership in healthcare innovation, advanced semiconductor integration, and rising demand for point-of-care diagnostics across medical, environmental, and food safety applications.
  • The US market benefits from strong R&D investment, regulatory support, and a mature healthcare infrastructure driving adoption of next-generation biosensing technologies. Key drivers propelling the US biosensors market include increasing prevalence of chronic diseases, growing consumer demand for wearable health monitoring devices, and accelerating digital health integration.
  • The US pharmaceutical and medical device sectors are investing heavily in biosensor development for drug discovery and personalized medicine applications.
  • Additionally, government initiatives and FDA approvals are facilitating faster commercialization of innovative biosensor solutions in the US market. The competitive landscape in the US is characterized by established semiconductor and medical device manufacturers alongside emerging biotech startups.
  • Strategic partnerships, acquisitions, and continuous innovation in miniaturization and sensitivity enhancement are shaping the US biosensors ecosystem through 2030..

Key Market Statistics

  • CAGR (2025-2030) 10.5% CAGR
  • Market Size, 2025 ~USD 4386.4 Million
  • Forecast, 2030 ~USD 7237.9 Million
  • Country US

US Biosensors Market Overview

Market Valuation Growth :

The US biosensors market is valued at $4,386.4 million in 2025 and is projected to reach $7,237.9 million by 2030, demonstrating strong market expansion driven by healthcare innovation and technological advancement.

US Leadership in Innovation :

The United States maintains a dominant position in biosensor development, leveraging advanced semiconductor integration, robust R&D infrastructure, and a concentration of leading medical device manufacturers and biotech companies.

Point-of-Care Diagnostics Demand :

Rising adoption of point-of-care testing solutions across US healthcare facilities, clinics, and home settings is accelerating biosensor deployment, particularly for rapid disease detection and chronic disease management.

Diverse Application Expansion :

US biosensor applications are expanding beyond medical diagnostics into environmental monitoring and food safety sectors, driven by regulatory requirements and consumer demand for safety and quality assurance.

US Biosensors Market Dynamics

  • FDA approvals and favorable reimbursement policies continue to accelerate market adoption across clinical and consumer segments.
  • The integration of artificial intelligence and IoT connectivity with biosensor platforms is creating new opportunities for remote patient monitoring and personalized medicine applications.
  • Additionally, heightened focus on pandemic preparedness and infectious disease surveillance is driving institutional investment in advanced diagnostic biosensor infrastructure throughout the US healthcare system..

Related Ecosystem

Sensors And Control

Top Technologies
    Top Companies

      Smart Home

      Top Technologies
        Top Companies

          Key Takeaways

          • The US biosensors market will grow from $4,386.4M (2025) to $7,237.9M (2030) at a 10.5% CAGR, outpacing global growth.
          • US healthcare innovation and FDA regulatory framework accelerate biosensor adoption in diagnostics and personalized medicine.
          • Wearable health monitoring and chronic disease management are primary growth catalysts in the US market.
          • The US competitive landscape combines established medical device leaders with innovative biotech startups driving technological advancement.

          Biosensors Market Report Scope

          Report Metric Details
          Base Year 2025
          Fastest Growing Segment HOME DIAGNOSTICS (Application)
          Forecast Period 2025–2030
          Growth Rate CAGR of 9.5% from 2025 to 2030
          Largest Segment NON-WEARABLE BIOSENSORS (Product)
          Market Size Base Year (Billions) ~USD 34.54 (2025)
          Revenue Forecast (Billions) ~USD 54.37 (2030)
          Segments Covered Type, Product, Application, Technology

          US Biosensors Market Report Segmentation

          4 segment dimensions are covered across the global market.

          By Type

          • Blood Gas & Electrolyte Detection
          • Bodywear
          • Cardiac Marker Detection
          • Cholesterol Testing
          • Coagulation Monitoring
          • Embedded Devices
          • Eyewear
          • Footwear
          • Glucose Monitoring
          • Infectious Disease Detection
          • Neckwear
          • Other Wearable Biosensors
          • Pregnancy Testing
          • Sensor Patches
          • Tumor/Cancer Marker Detection
          • Urinalysis Testing
          • Wristwear

          By Product

          • Non-Wearable Biosensors
          • Wearable Biosensors

          By Application

          • Biodefense
          • Environmental Monitoring
          • Food & Beverage
          • Food & Beverages
          • Home Diagnostic
          • Home Diagnostics
          • Poc
          • Research Lab
          • Research Labs

          By Technology

          • Electrochemical
          • Nanomechanical
          • Optical
          • Piezoelectric
          • Thermal

          Target Audience

          • Medical Device Manufacturers : US-based and international medical device companies need market data to develop biosensor-integrated diagnostic platforms, assess competitive positioning, and plan product launches in the high-growth US healthcare market.
          • Healthcare Providers & Institutions : Hospitals, diagnostic labs, and clinical networks require market intelligence to evaluate biosensor technology adoption, budget allocation for diagnostic infrastructure, and vendor selection for point-of-care solutions.
          • Biotech & Semiconductor Companies : US biotech firms and semiconductor manufacturers need detailed market forecasts to guide R&D investment, identify partnership opportunities, and develop next-generation biosensor technologies for American healthcare systems.
          • Investment & Private Equity Firms : Investors and PE firms evaluating biosensor companies require comprehensive US market data to assess portfolio company growth potential, identify acquisition targets, and make informed funding decisions.
          • Government & Regulatory Bodies : US FDA, NIH, and healthcare policy organizations use market research to understand biosensor adoption trends, inform regulatory frameworks, and allocate resources for healthcare innovation and pandemic preparedness initiatives.

          Key Companies in the US Biosensors Market

          CompanyHQOwnershipStrongest segments
          TSI INCChinaPublic CompanyTsingtao Beer (core and premium variants),Laoshan Beer,Hans Beer and other regional beers,
          X-FABGermanyPublic CompanyAnalog/Mixed-Signal Foundry (incl. automotive, industrial, consumer),MEMS and Sensor Platforms,Power (SiC, GaN, and related) and Silicon Photonics,
          LENOVOChinaPublic CompanySmall form factor / desktop PCs as signage players,Embedded / dedicated media players and thin clients,Tablets and smart devices as kiosks / POS displays,
          DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and bioproduction solutions),Life Sciences (genomics, analytical instruments, and research tools),Diagnostics (clinical instruments, consumables, and software),
          ABBOTT LABORATORIESUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
          MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio,
          BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Instruments and Systems,Life Science Reagents and Consumables,
          DUPONTUnited StatesPublic CompanyHealthcare & Water Technologies,Protective Materials and Medical Packaging (TYVEK),Construction Solutions (TYVEK house wrap, STYROFOAM, CORIAN),
          BIOSENSORS INTERNATIONAL GROUP, LTD.SingaporePrivate CompanyInterventional Cardiology (DES, BMS, balloons, catheters),Critical Care (pressure transducers, CVCs, PA catheters, pacing, embolectomy),Cardiac Diagnostic (imaging and clinical applications),
          DEXCOM, INC.United StatesPublic CompanyDexcom G7 and G7 15 Day,Dexcom G6,Dexcom ONE+ and value-focused CGM,
          MASIMOUnited StatesPrivate CompanySET and Rainbow SET pulse oximetry (including sensors and OEM),Brain function and hemodynamic monitoring,Hospital automation and connectivity (Patient SafetyNet, Iris, iSirona, Replica, UniView),
          UNIVERSAL BIOSENSORSAustraliaPublic CompanyPT/INR coagulation strips and Xprecia devices,Sentia wine testing products,Laboratory and coagulation testing services,

          TSI INC

          TSI Inc is a publicly traded company founded in 1903 and headquartered in China, employing 29,257 people. The company operates as a significant industrial enterprise with a long-established presence in its market.

          X-FAB

          X-FAB is a publicly traded semiconductor manufacturer founded in 1992 and headquartered in Germany, employing 4,300 people. The company specializes in analog and mixed-signal semiconductor fabrication services.

          LENOVO

          Lenovo is a publicly traded technology company founded in 1984 and based in China, operating as a major global manufacturer of computing devices and IT solutions.

          DANAHER CORPORATION

          Danaher Corporation is a publicly traded American conglomerate founded in 1969, employing 59,000 people across diversified business segments including life sciences, diagnostics, and environmental solutions.

          ABBOTT LABORATORIES

          Abbott Laboratories is a publicly traded pharmaceutical and healthcare company founded in 1888 and headquartered in the United States, employing 115,000 people globally. The company develops and manufactures pharmaceuticals, diagnostics, nutritional products, and medical devices.

          MEDTRONIC

          Medtronic is a publicly traded medical technology company founded in 1949 and headquartered in Ireland, employing 95,000 people. The company develops and manufactures medical devices and therapies across multiple healthcare specialties.

          BIO-RAD LABORATORIES, INC.

          Bio-Rad Laboratories, Inc. is a publicly traded company founded in 1952 and based in the United States, employing 7,450 people. The company manufactures and distributes life science research products and clinical diagnostics solutions.

          DUPONT

          DuPont is a publicly traded chemical and materials company founded in 2015 and headquartered in the United States, employing 15,000 people. The company produces specialty chemicals, advanced materials, and industrial solutions.

          BIOSENSORS INTERNATIONAL GROUP, LTD.

          Biosensors International Group, Ltd. is a private medical device company founded in 1990 and based in Singapore, employing 312 people. The company specializes in the development and manufacture of interventional cardiology devices.

          DEXCOM, INC.

          Dexcom, Inc. is a publicly traded medical technology company founded in 1999 and based in the United States, employing 11,050 people. The company specializes in continuous glucose monitoring systems for diabetes management.

          MASIMO

          Masimo is a privately held medical technology company founded in 1989 and based in the United States, employing 2,200 people. The company develops and manufactures noninvasive monitoring technologies and sensors.

          UNIVERSAL BIOSENSORS

          Universal Biosensors is a publicly traded diagnostics company founded in 2001 and based in Australia, employing 76 people. The company develops and manufactures rapid diagnostic test devices.

          Reasons to Buy this Report

          • Strategic Market Sizing : Obtain precise US market valuation data ($4.4B in 2025) and 5-year forecasts to accurately assess market opportunity, competitive positioning, and investment potential in the biosensor sector.
          • Growth Trajectory Analysis : Understand the 10.5% CAGR specific to the US market, outpacing the global 9.5% rate, enabling informed decisions on resource allocation and market entry timing for biosensor solutions.
          • Application-Specific Insights : Gain detailed intelligence on US demand drivers across medical diagnostics, environmental monitoring, and food safety applications to tailor product development and go-to-market strategies.
          • Competitive Landscape Intelligence : Identify key US market players, emerging startups, and technology trends shaping the biosensor ecosystem to benchmark performance and identify partnership or acquisition opportunities.
          • Regulatory & Reimbursement Context : Access insights on FDA approval pathways, insurance coverage trends, and healthcare policy factors specific to the US market that influence biosensor adoption and commercialization success.

          Frequently asked questions

          What is the current size of the US biosensors market?

          The US biosensors market is valued at $4,386.4 million in 2025 and is expected to reach $7,237.9 million by 2030.

          What is the growth rate of the US biosensors market?

          The US biosensors market is projected to grow at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2030.

          What are the main applications driving the US biosensors market?

          Key applications in the US include point-of-care diagnostics, wearable health monitoring devices, drug discovery, personalized medicine, and environmental and food safety testing.

          Which factors are accelerating biosensor adoption in the US?

          Major factors include rising chronic disease prevalence, consumer demand for wearable health devices, FDA regulatory support, strong R&D investment, and digital health integration across the US healthcare system.

          Who are the main competitors in the US biosensors market?

          The US market includes established semiconductor and medical device manufacturers, specialized biosensor companies, and emerging biotech startups engaged in strategic partnerships and acquisitions.

          RESEARCH METHODOLOGY

          The study involved major activities in estimating the current size of the biosensors market. Exhaustive secondary research was done to collect information on biosensors. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the biosensor.

          Secondary Research

          Various secondary sources were referred to in the secondary research process to identify and collect information relevant to this study. Secondary sources included annual reports, press releases, and investor presentations of companies; white papers, certified publications, and articles from recognized authors; directories; and databases. Secondary research was mainly carried out to obtain critical information about the industry’s supply chain, value chain, the pool of key players, and market classification and segmentation according to industry trends, geographic markets, and key developments from both market- and technology-oriented perspectives. Secondary sources included corporate filings (such as annual reports, investor presentations, and financial statements); trade, business, and professional associations; white papers; IoT technologies journals and certified publications; articles by recognized authors; gold- and silver-standard websites; directories; and databases. Data was also collected from secondary sources, such as the Semiconductor Industry Association, Global Semiconductor Alliance, and Taiwan Semiconductor Industry Association.

          Secondary research was mainly used to obtain critical information about the industry's supply chain and value chain, the total pool of key players, market classification and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments from both the market and technology-oriented perspectives. Secondary data has been gathered and analyzed to determine the overall market size, which has also been validated by primary research.

          Primary Research

          Extensive primary research was conducted after understanding and analyzing the current scenario of the biosensors market through secondary research. Primary interviews were held with key opinion leaders from the demand and supply sides in four key regions: North America, Europe, Asia Pacific, and the rest of the world. Nearly 25% of the primary interviews were held with the demand side and 75% with the supply side. The primary data was gathered primarily through telephonic interviews, which were 80% of the total primary interviews. Surveys and e-mails were also utilized to gather data.

          Biosensors Market
 Size, and Share

          Note: Three tiers of companies are defined based on their total revenue as of 2024; tier 1: revenue more than or equal to USD 500 million, tier 2: revenue between USD 100 million and USD 500 million, and tier 3: revenue less than or equal to USD 100 million. Other designations include sales and marketing executives, researchers, and members of various biosensor organizations.

          To know about the assumptions considered for the study, download the pdf brochure

          Market Size Estimation

          In this report, both the top-down and bottom-up approaches were implemented to estimate and validate the size of the biosensors market and various other dependent submarkets. Secondary research identified key players in this market, and their market shares in the respective regions were determined through primary and secondary research.

          This entire research methodology included the study of annual and financial reports of top companies, as well as interviews with experts (such as CEOs, VPs, directors, and marketing executives) for key insights (both quantitative and qualitative). All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study were accounted for, viewed in detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data was consolidated and supplemented with detailed inputs and analysis from MarketsandMarkets and presented in this report. The figures below show the overall market size estimation process employed for this study.

          Bottom-Up Approach

          • Key players in the biosensors market were identified through secondary research, and their global market share was determined through primary and secondary research.
          • The research methodology included a study of annual and quarterly financial reports, regulatory filings of major market players (public), and interviews with industry experts for detailed market insights.
          • All biosensor penetration rates, percentage shares, splits, and breakdowns for the biosensors market were determined using secondary sources and verified through primary sources.
          • All key macroindicators influencing the revenue growth of market segments and subsegments were considered, examined in detail, validated through primary research, and analyzed to produce accurate quantitative and qualitative data.
          • The market data gathered was consolidated, enhanced with detailed inputs, analyzed, and presented in this report.

          Top-Down Approach

          • Focusing initially on the top-line investments and expenditures made in the biosensor ecosystem, splitting the key market areas into component, type, product, technology, and region, and listing key developments
          • Identifying all leading players and end users in the biosensors market based on product, type, technology, and application through secondary research and fully verifying them through a brief discussion with industry experts
          • Analyzing revenues, product mix, geographic presence, and key applications served by all identified players to estimate and arrive at percentage splits for all key segments
          • Discussing splits with industry experts to validate the information and identify key growth pockets across all key segments
          • Breaking down the total market based on verified splits and key growth pockets across all segments

          Biosensors Market : Top-Down and Bottom-Up Approach

          Biosensors Market Top Down and Bottom Up Approach

          Data Triangulation

          After arriving at the overall size of the biosensors market from the estimation process explained above, the market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed (wherever applicable) to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. The biosensors market size was validated using both top-down and bottom-up approaches.

          Market Definition

          Biosensors are semiconductor devices designed to detect biological responses using transducers that convert these responses into electrical signals. They achieve this by combining a biological recognition element (bioreceptor) with a physicochemical transducer. The bioreceptor specifically interacts with a particular biological analyte. The transducer then converts this interaction into a measurable signal, such as an electrical current, optical change, mass change, or thermal signal, which relates to the analyte’s concentration. Common bioreceptors include enzymes, antibodies, nucleic acids, cells, or microorganisms. They are used as analytical tools to deliver qualitative or quantitative results in detecting protein or nucleic acid targets.

          Key Stakeholders

          • Semiconductor Industry Association
          • Global Semiconductor Alliance
          • European Semiconductor Industry Association
          • Taiwan Semiconductor Industry Association
          • International Diabetes Federation (IDF)
          • American Diabetes Association (ADA)
          • National Biodefense Analysis and Countermeasures Center (NBACC).
          • IEEE
          • Educational Institutions Research/White Papers (Published by Communication Organizations)
          • Investor Presentations and Annual Reports of Key Market Players

          Report Objectives

          • To define, describe, and forecast the biosensors market, by type, product, technology, application, and region, in terms of value
          • To define, describe, and forecast the global biosensors market by product, in terms of volume
          • To forecast the sizes of various segments with respect to the four major regions: North America, Europe, Asia Pacific, and Rest of the World (RoW)
          • To provide a detailed analysis of the biosensors supply chain
          • To strategically analyze the micromarkets with respect to individual growth trends and prospects, and their contributions to the total market
          • To analyze competitive developments, such as expansions, agreements, partnerships, acquisitions, product developments, and research & development (R&D), in the biosensors market
          • To analyze the opportunities for market players and provide details of the market's competitive landscape
          • To benchmark the market players using the proprietary company evaluation matrix framework, which analyzes the market players on various parameters within the broad categories of business strategy excellence and strength of product portfolios
          • To strategically profile the key players and comprehensively analyze their market positions in terms of ranking and core competencies, along with a detailed competitive landscape of the market
          • To analyze the supply chain, ecosystem, trend/disruptions impacting customer business, technologies, trade & patent scenario, key conferences & events, regulations, and conduct Porter’s five force analysis

          Available customizations:

          With the market data given, MarketsandMarkets offers customizations according to the company’s specific needs. The following customization options are available for the report:

          Company Information

          • Detailed analysis and profiling of additional market players (up to 7)

          Get the Full Biosensors Market Report

          Full forecast, segment splits, and company analysis for all Biosensors Market.

          Need a Tailored Report?

          Customize this report to your needs

          Get 10% FREE Customization

          Customize This Report
          Fact checked
          DMCA.com Protection Status